Suppr超能文献

人种差异对半枝莲病临床表现的影响:一项多中心前瞻性研究。

The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study.

机构信息

Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.

Department of Internal Medicine, Pulmonary and Critical Care, University of Iowa, 200 Hawkins Dr, Iowa City, IA, 52246, USA.

出版信息

Respir Med. 2021 Oct;187:106564. doi: 10.1016/j.rmed.2021.106564. Epub 2021 Aug 9.

Abstract

OBJECTIVE

To study how demographic differences impact disease manifestation of sarcoidosis using the WASOG tool in a large multicentric study.

METHODS

Clinical data regarding 1445 patients with sarcoidosis from 14 clinical sites in 10 countries were prospectively reviewed from Feb 1, 2020 to Sep 30, 2020. Organ involvement was evaluated for the whole group and for subgroups differentiated by sex, race, and age.

RESULTS

The median age of the patients at diagnosis was 46 years old; 60.8% of the patients were female. The most commonly involved organ was lung (96%), followed by skin (24%) and eye (22%). Black patients had more multiple organ involvement than White patients (OR = 3.227, 95% CI: 2.243-4.643) and females had more multiple organ involvement than males (OR = 1.238, 95% CI: 1.083-1.415). Black patients had more frequent involvement of neurologic, skin, eye, extra thoracic lymph node, liver and spleen than White and Asian patients. Women were more likely to have eye (OR = 1.522, 95%CI: 1.259-1.838) or skin involvement (OR = 1.369, 95%CI: 1.152-1.628). Men were more likely to have cardiac involvement (OR = 1.326, 95%CI: 1.096-1.605). A total of 262 (18.1%) patients did not receive systemic treatment for sarcoidosis. Therapy was more common in Black patients than in other races.

CONCLUSION

The initial presentation and treatment of sarcoidosis was related to sex, race, and age. Black and female individuals are found to have multiple organ involvement more frequently. Age at diagnosis<45, Black patients and multiple organ involvement were independent predictors of treatment.

摘要

目的

利用 WASOG 工具,在一项大型多中心研究中,研究人口统计学差异如何影响结节病的疾病表现。

方法

从 2020 年 2 月 1 日至 2020 年 9 月 30 日,前瞻性地审查了来自 10 个国家 14 个临床地点的 1445 例结节病患者的临床数据。对所有患者和按性别、种族和年龄分组的亚组进行了器官受累评估。

结果

患者的中位诊断年龄为 46 岁;60.8%的患者为女性。最常受累的器官是肺部(96%),其次是皮肤(24%)和眼睛(22%)。与白人患者相比,黑人患者多器官受累的比例更高(OR=3.227,95%CI:2.243-4.643),女性多器官受累的比例高于男性(OR=1.238,95%CI:1.083-1.415)。黑人患者更常发生神经系统、皮肤、眼睛、胸外淋巴结、肝脏和脾脏受累,而白人患者和亚洲患者则较少发生此类受累。女性更易发生眼部(OR=1.522,95%CI:1.259-1.838)或皮肤受累(OR=1.369,95%CI:1.152-1.628)。男性更易发生心脏受累(OR=1.326,95%CI:1.096-1.605)。共有 262 例(18.1%)患者未接受结节病的全身治疗。黑人患者的治疗比例高于其他种族。

结论

结节病的初始表现和治疗与性别、种族和年龄有关。黑人及女性个体更常出现多器官受累。诊断年龄<45 岁、黑人患者和多器官受累是治疗的独立预测因素。

相似文献

1
The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study.
Respir Med. 2021 Oct;187:106564. doi: 10.1016/j.rmed.2021.106564. Epub 2021 Aug 9.
3
Clinical characteristics of patients in a case control study of sarcoidosis.
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1885-9. doi: 10.1164/ajrccm.164.10.2104046.
5
Extrapulmonary involvement in patients with sarcoidosis in Turkey.
Respirology. 2011 Apr;16(3):446-50. doi: 10.1111/j.1440-1843.2010.01878.x.
7
Risk factors for ocular sarcoidosis.
Doc Ophthalmol. 1989 Aug;72(3-4):287-96. doi: 10.1007/BF00153496.
8
Phenotypes of organ involvement in sarcoidosis.
Eur Respir J. 2018 Jan 25;51(1). doi: 10.1183/13993003.00991-2017. Print 2018 Jan.
9
Demographic-related variations in posterior segment ocular sarcoidosis.
Ophthalmology. 2004 Feb;111(2):357-62. doi: 10.1016/S0161-6420(03)00793-0.
10
Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan.
Respir Med. 2015 Feb;109(2):272-8. doi: 10.1016/j.rmed.2014.12.012. Epub 2015 Jan 3.

引用本文的文献

2
Race Comparisons in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium.
Circ Arrhythm Electrophysiol. 2025 Jul;18(7):e013670. doi: 10.1161/CIRCEP.124.013670. Epub 2025 Jun 25.
3
Clinical characteristics of patients with pulmonary sarcoidosis treated with systemic steroids in Japan.
Front Med (Lausanne). 2025 May 30;12:1567334. doi: 10.3389/fmed.2025.1567334. eCollection 2025.
6
The textures of sarcoidosis: quantifying lung disease through variograms.
Phys Med Biol. 2025 Jan 13;70(2):025004. doi: 10.1088/1361-6560/ada19c.
7
Association of Area Deprivation Index with Adherence to Proposed Regimen in Patients with Sarcoidosis in Detroit, Michigan.
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Jun 28;41(2):e2024031. doi: 10.36141/svdld.v41i2.15587.
8
The textures of sarcoidosis: quantifying lung disease through variograms.
medRxiv. 2024 May 20:2024.05.20.24307618. doi: 10.1101/2024.05.20.24307618.
9
Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches.
Front Med (Lausanne). 2022 Oct 12;9:991783. doi: 10.3389/fmed.2022.991783. eCollection 2022.
10
Sex and Gender in Lung Diseases and Sleep Disorders: A State-of-the-Art Review: Part 2.
Chest. 2023 Feb;163(2):366-382. doi: 10.1016/j.chest.2022.08.2240. Epub 2022 Sep 29.

本文引用的文献

1
Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period.
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(3):e2020001. doi: 10.36141/svdld.v37i3.9362. Epub 2020 Sep 30.
2
Clinical characteristics of sarcoidosis patients in the United States versus China.
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(3):209-216. doi: 10.36141/svdld.v34i3.5727. Epub 2020 Mar 9.
3
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis.
Eur Respir Rev. 2020 Mar 20;29(155). doi: 10.1183/16000617.0146-2019. Print 2020 Mar 31.
4
Clinical Features of Extrapulmonary Sarcoidosis Without Lung Involvement.
Chest. 2018 Aug;154(2):349-356. doi: 10.1016/j.chest.2018.02.003. Epub 2018 Feb 14.
5
Clinical Characteristics of Ocular Sarcoidosis: A Population-Based Study 1976-2013.
Ocul Immunol Inflamm. 2019;27(3):389-395. doi: 10.1080/09273948.2017.1386791. Epub 2017 Oct 12.
6
Repository corticotropin for Chronic Pulmonary Sarcoidosis.
Lung. 2017 Jun;195(3):313-322. doi: 10.1007/s00408-017-9994-4. Epub 2017 Mar 28.
7
Sarcoidosis in America. Analysis Based on Health Care Use.
Ann Am Thorac Soc. 2016 Aug;13(8):1244-52. doi: 10.1513/AnnalsATS.201511-760OC.
8
Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden.
Eur Respir J. 2016 Dec;48(6):1690-1699. doi: 10.1183/13993003.00477-2016. Epub 2016 Jul 28.
9
Cardiac Sarcoidosis: Is it More Common in Men?
Lung. 2016 Feb;194(1):61-6. doi: 10.1007/s00408-015-9805-8. Epub 2015 Sep 28.
10
Sarcoidosis in the national veteran population: association of ocular inflammation and mortality.
Ophthalmology. 2015 May;122(5):934-8. doi: 10.1016/j.ophtha.2015.01.003. Epub 2015 Feb 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验